Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction.
Protein Cell
; 12(7): 586-591, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1384664
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Protein Cell
Journal subject:
Biochemistry
Year:
2021
Document Type:
Article
Affiliation country:
S13238-020-00803-W
Similar
MEDLINE
...
LILACS
LIS